These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8380367)

  • 21. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII).
    Christie G; Barton A; Bolognese B; Buckle DR; Cook RM; Hansbury MJ; Harper GP; Marshall LA; McCord ME; Moulder K; Murdock PR; Seal SM; Spackman VM; Weston BJ; Mayer RJ
    Eur J Immunol; 1997 Dec; 27(12):3228-35. PubMed ID: 9464810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Localization of an intron EBV-responsive enhancer and characterization of its cognate GC-box binding factors.
    Lacy J; Roth G; Shieh B
    J Immunol; 1994 Dec; 153(12):5537-48. PubMed ID: 7989755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD23 molecule acts as a galactose-binding lectin in the cell aggregation of EBV-transformed human B-cell lines.
    Kijimoto-Ochiai S; Uede T
    Glycobiology; 1995 Jun; 5(4):443-8. PubMed ID: 7579799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.
    Shcherbina A; Rosen FS; Remold-O'Donnell E
    J Immunol; 1999 Dec; 163(11):6314-20. PubMed ID: 10570326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
    Young L; Alfieri C; Hennessy K; Evans H; O'Hara C; Anderson KC; Ritz J; Shapiro RS; Rickinson A; Kieff E
    N Engl J Med; 1989 Oct; 321(16):1080-5. PubMed ID: 2552313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immortalization of Epstein-Barr virus-infected CD23-negative B lymphocytes by the addition of B cell growth factor.
    Azim T; Allday MJ; Crawford DH
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():665-71. PubMed ID: 2155999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Identification of EBV-responsive regulatory elements in intron 1.
    Lacy J; Rudnick H
    J Immunol; 1992 Mar; 148(5):1554-60. PubMed ID: 1311350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome.
    Simon HU; Mills GB; Hashimoto S; Siminovitch KA
    J Clin Invest; 1992 Oct; 90(4):1396-405. PubMed ID: 1401074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
    Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
    Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection.
    Roberts ML; Luxembourg AT; Cooper NR
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3077-85. PubMed ID: 9000100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Epstein-Barr virus-binding site on CD21 is involved in CD23 binding and interleukin-4-induced IgE and IgG4 production by human B cells.
    Henchoz-Lecoanet S; Jeannin P; Aubry JP; Graber P; Bradshaw CG; Pochon S; Bonnefoy JY
    Immunology; 1996 May; 88(1):35-9. PubMed ID: 8707347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
    Luo HY; Hofstetter H; Banchereau J; Delespesse G
    J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the low-affinity IgE Fc receptor (Fc epsilon RII/CD23) by Leishmania chagasi.
    Noben NN; Wilson ME; Lynch RG
    Int Immunol; 1994 Jul; 6(7):935-45. PubMed ID: 7947462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
    Ling NR; Lowe JA
    Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.
    Chomarat P; Briolay J; Banchereau J; Miossec P
    Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
    Peng M; Lundgren E
    Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble Fc epsilon RII/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble Fc epsilon RII/CD23.
    Yoshikawa T; Nanba T; Kato H; Hori K; Inamoto T; Kumagai S; Yodoi J
    Immunomethods; 1994 Feb; 4(1):65-71. PubMed ID: 8069529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphasic effect of transforming growth factor-beta on Epstein-Barr virus-induced activation of human tonsillar B cells.
    Altiok A; Jädersten M; Magyarlaki T; Klein E
    Immunol Lett; 1994 May; 40(2):111-5. PubMed ID: 8088869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the human IgE receptor (Fc epsilonRII/CD23) by Epstein-Barr virus (EBV): Ku autoantigen binds specifically to an EBV-responsive enhancer of CD23.
    Shieh B; Schultz J; Guinness M; Lacy J
    Int Immunol; 1997 Dec; 9(12):1885-95. PubMed ID: 9466316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.